ALLIANCE PHARMA PLCALLIANCE PHARMA PLCALLIANCE PHARMA PLC

ALLIANCE PHARMA PLC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪245.96 M‬GBP
−0.05GBP
‪−33.14 M‬GBP
‪180.68 M‬GBP
‪389.70 M‬
Beta (1Y)
0.97

About ALLIANCE PHARMA PLC


CEO
Nick Sedgwick
Headquarters
Chippenham
Founded
2001
ISIN
GB0031030819
FIGI
BBG00MJVM392
Alliance Pharma Plc is a holding company, which engages in the provision of acquisition, marketing, and distribution of healthcare and pharmaceutical products. It holds marketing rights to a range of healthcare brands and prescription medicines. The company was founded by John Dawson in 1996 and is headquartered in Chippenham, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on TURQUOISE exchange ALLIANCE PHARMA PLC stocks are traded under the ticker APHL.
We've gathered analysts' opinions on ALLIANCE PHARMA PLC future price: according to them, APHL price has a max estimate of 85.00 GBX and a min estimate of 42.00 GBX. Watch APHL chart and read a more detailed ALLIANCE PHARMA PLC stock forecast: see what analysts think of ALLIANCE PHARMA PLC and suggest that you do with its stocks.
APHL reached its all-time high on Mar 28, 2022 with the price of 121.80 GBX, and its all-time low was 25.05 GBX and was reached on May 8, 2024. View more price dynamics on APHL chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track ALLIANCE PHARMA PLC financials in yearly and quarterly reports right on TradingView.
ALLIANCE PHARMA PLC is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
ALLIANCE PHARMA PLC revenue for the last half-year amounts to ‪84.80 M‬ GBX, despite the estimated figure of ‪84.80 M‬ GBX. In the next half-year revenue is expected to reach ‪102.90 M‬ GBX.
APHL net income for the last half-year is ‪4.66 M‬ GBP, while the previous report showed ‪−38.24 M‬ GBP of net income which accounts for 112.19% change. Track more ALLIANCE PHARMA PLC financial stats to get the full picture.
As of Nov 26, 2024, the company has 292.00 employees. See our rating of the largest employees — is ALLIANCE PHARMA PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALLIANCE PHARMA PLC EBITDA is ‪51.21 M‬ GBP, and current EBITDA margin is 24.90%. See more stats in ALLIANCE PHARMA PLC financial statements.
Like other stocks, APHL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALLIANCE PHARMA PLC stock right from TradingView charts — choose your broker and connect to your account.